Manufacturers Life Insurance Company, The Athira Pharma, Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $38,940 - $190,867	-14,212 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$8.96 - $13.51 $127,339 - $192,004	14,212 New	14,212 $191,000
Q1 2022 May 20, 2022	SELL	$8.96 - $13.51 $29,630 - $44,677	-3,307 Reduced 18.88%	14,212 $192,000
Q4 2021 Feb 16, 2022	SELL	$9.17 - $16.39 $22,879 - $40,893	-2,495 Reduced 12.47%	17,519 $228,000
Q3 2021 Nov 12, 2021	BUY	$9.15 - $11.09 $8,701 - $10,546	951 Added 4.99%	20,014 $188,000
Q2 2021 Aug 12, 2021	BUY	$10.24 - $20.87 $195,205 - $397,844	19,063 New	19,063 $195,000
Q1 2021 May 03, 2021	SELL	$16.9 - $29.77 $128,203 - $225,835	-7,586 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.48 - $34.3 $125,017 - $260,199	7,586 New	7,586 $260,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.